1. Cost-effectiveness of denosumab versus zoledronic acid for preventing skeletal-related events in the Czech Republic. (3rd August 2017) Authors: Cristino, Joaquim; Finek, Jíndřich; Jandova, Petra; Kolek, Martin; Pásztor, Bálint; Giannopoulou, Christina; Qian, Yi; Brezina, Tomas; Lothgren, Mickael Journal: Journal of medical economics Issue: Volume 20:Number 8(2017) Page Start: 799 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗